Active	Status	Sponsor type	Region	Phase	Filter
12 Active 0 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Li, Dan
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis	Recruiting	4	364	RoW	Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline	Shanghai Pulmonary Hospital, Shanghai, China	Bronchiectasis Adult, Pseudomonas Aeruginosa Infection	10/25	12/25
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder	Recruiting	3	1041	RoW	YZJ-1139 20mg, YZJ-1139 40mg, Placebo	Shanghai Haiyan Pharmaceutical Technology Co., Ltd.	Insomnia Disorder	12/24	12/24
TQB2450-III-13, NCT06475599: Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer	Not yet recruiting	3	420	RoW	Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Endometrial Cancer	12/27	06/29
NCT04727008: CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma	Recruiting	1	12	RoW	CXCR4 modified anti-BCMA CAR T cells	Sichuan University	Multiple Myeloma	12/25	12/25
NCT06299033: A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke	Recruiting	1	21	RoW	hNPC01	Hopstem Biotechnology Inc.	Chronic Ischemic Stroke	08/24	12/25
OASIS, NCT06063317: A Study of OnCARlytics (CF33-CD19) in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors	Recruiting	1	33	US	CF33-CD19 IT, CF33-CD19 IV, Blinatumomab, Blincyto	Imugene Limited	Solid Tumor, Adult	06/27	05/29
MAST, NCT05346484: A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors	Recruiting	1	100	US, RoW	CF33-hNIS, VAXINIA, HOV2, Pembrolizumab, KEYTRUDA®	Imugene Limited	Solid Tumor, Solid Carcinoma, Solid Tumor, Adult, Metastatic Cancer, Advanced Solid Tumor, Cholangiocarcinoma, Bile Duct Cancer	12/24	01/25
NCT05477927: Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases	Recruiting	1	58	RoW	Dual-targeting VEGFR1 and PD-L1 CAR-T cells	Sichuan University	Malignant Peritoneal Effusion, Malignant Ascites, Serous Cavity Metastatises	12/24	12/24
NCT06084286: Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients With CLDN18.2-positive Advanced Solid Tumors	Not yet recruiting	1	29	RoW	Dual-targeting CLDN18.2 and PD-L1 CAR-T cells	Sichuan University	Advanced Solid Tumor	10/26	10/26
NCT06189586: Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD	Enrolling by invitation	N/A	100	RoW	aerosol inhalation of glucocorticoids, intravenous injection of glucocorticoids	Dong Yang, Jilin University	Acute Exacerbation of Chronic Obstructive Pulmonary Disease	12/24	07/25
KCLD, NCT06722937: The Collagen Factors of Rapid Progression of Keratoconus in Children.	Recruiting	N/A	160	RoW	Observation	Zhongshan Ophthalmic Center, Sun Yat-sen University	Keratoconus	04/25	04/25
MRI-CervPain, NCT06217029: Magnetic Resonance Imaging Study on Young and Middle-aged Patients With Cervical Spondylotic Pain	Recruiting	N/A	80	RoW	physiotherapy and maxillary traction, massage therapy	First Affiliated Hospital Xi'an Jiaotong University	Neck Pain	12/26	12/27